Please provide your email address to receive an email when new articles are posted on . Last year the FDA cleared ellacor, a minimally invasive micro-coring device, for the treatment of moderate to ...
WOBURN, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytrellis Biosystems, Inc. (“Cytrellis” or the “Company”), a medical aesthetics company bridging the gap in skin restoration, today announced that it ...
Please provide your email address to receive an email when new articles are posted on . The ellacor 2.0 system uses micro-coring technology to improve the appearance of sagging skin and wrinkles. The ...
WOBURN, Mass., May 2, 2023 /PRNewswire/ -- Cytrellis ® Biosystems, a pioneer in novel medical aesthetic solutions, announces the appointment of Dr. Shiv Sabesan as Chief Technology Officer (CTO). In ...
WOBURN, Mass., March 17, 2023 /PRNewswire/ -- Cytrellis Biosystems, a pioneer in novel medical aesthetic solutions, celebrates the delivery of the 100 th ellacor system with Micro-Coring Technology.
(MENAFN- GlobeNewsWire - Nasdaq) New indication significantly expands applications for ellacor to treat sagging skin on body areas outside of the face WOBURN, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results